GOSSVSGPCR• 12 Months (Normalized)
GOSS vs GPCR (Gossamer Bio Inc. vs Structure Therapeutics Inc.)
Showing Closing Date Range from Sep, 14, 2025 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GOSS Performance $10.7
+236.48%
Gossamer Bio Inc.
Normalized Baseline0.00%
GPCR Performance $38.44
+90.3%
Structure Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
+146.18%
GOSS outperforming by 146.18%
GOSSGPCR
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GOSS GPCR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | GOSS Price | GOSS Gain (%) | GPCR Price | GPCR Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $10.70 | +236.48% | $38.44 | +90.30% | +146.18% |
| Sep 11, 2026 | $10.73 | +237.42% | $38.66 | +91.39% | +146.03% |
| Sep 10, 2026 | $11.36 | +257.23% | $39.55 | +95.79% | +161.44% |
| Sep 09, 2026 | $12.80 | +302.52% | $41.23 | +104.11% | +198.41% |
| Sep 08, 2026 | $14.40 | +352.83% | $40.38 | +99.90% | +252.93% |
| Sep 04, 2026 | $14.00 | +340.25% | $47.34 | +134.36% | +205.89% |
| Sep 03, 2026 | $14.05 | +341.76% | $47.34 | +134.36% | +207.40% |
| Sep 02, 2026 | $0.17 | -94.56% | $47.80 | +136.63% | -231.19% |
| Sep 01, 2026 | $0.17 | -94.75% | $47.13 | +133.32% | -228.07% |
| Aug 31, 2026 | $0.17 | -94.65% | $45.91 | +127.28% | -221.93% |
| Aug 28, 2026 | $0.17 | -94.65% | $47.37 | +134.50% | -229.15% |
| Aug 27, 2026 | $0.17 | -94.65% | $49.22 | +143.66% | -238.31% |
| Aug 26, 2026 | $0.17 | -94.53% | $49.35 | +144.31% | -238.84% |
| Aug 25, 2026 | $0.21 | -93.55% | $49.92 | +147.13% | -240.68% |
| Aug 24, 2026 | $0.18 | -94.50% | $49.01 | +142.62% | -237.12% |
Page 1 of 17